2-(4-Chlorophenyl)-2-(pyridin-2-yl)acetonitrile, 95+%, 1g

(R)-2-Amino-2-(4-chlorophenyl)ethanol hydrochloride, 97.0%, 250mg

3,3',3''-((1,3,5-Triazine-2,4,6-triyl)tris(azanediyl))tribenzoic acid, 97%, 1g

Iron(III) oxide tablets 99.9% ca. 10x6 mm 100 g

tert-Butyl (2-bromo-5-methoxyphenyl)carbamate, 95.0%, 1g

1,3-dimethyl-6-(4-methylphenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 1g

Methyl 4-nitro-1H-indazole-6-carboxylate, 95.0%, 250mg

N -Benzyl-oxalamic acid, 1g

(Z)-4,4'-(1,2-Diphenylethene-1,2-diyl)dibenzonitrile, 97%, 1g

2-(Chloromethyl)pyrimidin-4-amine, 95.0%, 5g

6-Bromo-7-methyl-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 250mg

2,2-Difluoro-2-(pyridin-3-yl)acetic acid, 95+%, 250mg

4-Bromo-7-methylbenzo[c][1,2,5]thiadiazole, 95.0%, 250mg